Rates of nonrelapse mortality and 3-year overall survival were similar between patients 55 to 64 years old and patients 65 years or older who underwent transplantation. Patients who are older and have ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
The Structural Heart Occlusion Devices market presents opportunities in offering minimally invasive solutions for congenital heart defects, enhancing recovery. Insights on market trends, competitive ...
DUBLIN--(BUSINESS WIRE)--The "US Market Report for Atrial and Ventricular Septal Defect Devices 2018 - MedCore" report has been added to Research and Markets' offering. VSDs are defects in the ...
Please provide your email address to receive an email when new articles are posted on . Artificial intelligence effectively detected atrial septal defect on ECGs from three separate institutions.
When expectant parents imagine their baby’s beating heart, few consider the possibility of a structural issue being present from day one. Yet for thousands of families each year, this becomes reality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback